Organic Active Ingredients TRIZ Cases

Bicyclic nucleoside compounds suppress viral replication while reducing liver complications associated with existing therapies.

Oseltamivir derivative nanoparticles bind resistant influenza viruses, enabling direct visual detection without additional confirmation steps.

Novel benzylamino-oxoethyl benzamide analogs mitigate endoplasmic reticulum stress while reducing toxicity associated with high-dose chemical chaperones.

A 7beta-hydroxycholesterol derivative dissolved in a vegetable oil vehicle enables oral administration of the therapeutic agent.

Topical ruxolitinib treats refractory lichen planus by delivering JAK inhibition locally, avoiding systemic side effects while reducing lesions.

A ternary conjugate links thrombolytic and targeting peptides with an imidazoline scavenger.

Traditional Chinese medicine mixture promotes stem cell directional differentiation into cardiomyocytes using synergistic active ingredients.

Bicyclic pyrimidine derivatives inhibit autotaxin-mediated pain pathways, offering sustained efficacy without invasive administration.

Quinazoline core inhibitors resolve the trade-off between therapeutic reliability and molecular complexity by selectively targeting IRAK4 ATP-binding pockets.

Porous silica particles deliver retinoic acid via endocytosis, resolving the trade-off between neural differentiation efficiency and cell viability.

A nutritional composition comprising human milk oligosaccharides stimulates saccharolytic bacteria to produce beneficial metabolites.

Specific oxycodone and buprenorphine ratios utilize the partial agonist ceiling effect to limit respiratory depression while maintaining analgesia.

Combining an anti-TROP2 antibody-drug conjugate with an ATR inhibitor enhances antitumor efficacy through dual mechanism action.

Formula I compounds antagonize the mineralocorticoid receptor, addressing suboptimal hypertension and heart failure treatments.

A random copolymer induces caspase activity in colorectal cancer cells, addressing laxative side effects of conventional polymeric treatments.

An intravesical device releases oxaliplatin continuously to maintain therapeutic concentrations in bladder tissue.

Modulating miR-127 expression arrests chronic kidney disease progression by inhibiting mesenchymal transition, avoiding high costs of renal replacement therapy.

Chemical compounds replace cold stimuli to induce adipocyte browning, treating obesity without complex environmental control.

Macrocyclic compounds form high affinity ternary complexes with Ras and cyclophilin A to inhibit activity in refractory cancers.

Novel bicyclic pyrazolo pyrimidine compounds inhibit respiratory syncytial virus replication through specific molecular interactions.

Permeation enhancers improve intestinal stability and bioavailability of oral antisense oligonucleotides for liver targeting.

Pyridine and pyrimidine derivatives inhibit hepatocyte growth factor receptor to block cancer cell proliferation and angiogenesis.

Peripheral opioid receptor agonists provide pain relief without central nervous system side effects.

Mechanical extrusion with natural oils extracts THCA from cannabis blends while preserving sensitive terpenoids and cannabinoids.

Upmodulating KCC2 restores stepping function by transforming dysfunctional spinal circuits into functional states.

A skin gel preparation blends a di-chain cationic surfactant with oil and lower alcohol to prevent precipitation.

Opicapone inhibits COMT to increase levodopa bioavailability, reducing fluctuation-related pain.

Modified taxanes derivatives overcome P-gp efflux resistance to achieve 10.7% absolute oral bioavailability without co-solvent toxicity.

A structured solid-solution framework uses amphiphilic polymer micelles to enhance drug solubility and release rates.

Acetyl chrysin Mannich base derivatives form stable six-member ring structures to enhance bioavailability as CDK1 inhibitors.

Tryptophol derivatives disrupt quorum sensing pathways to reduce biofilm formation, addressing antibiotic resistance without direct killing.

A transdermal precursor uses a folded release liner to separate drug and adhesive layers during storage.

Red cell-derived microparticles promote hemostasis via phosphatidylserine display, resolving bleeding control challenges amid limited blood supply.

An implant releases stimulating substances to promote osteoclast formation and activity.

Formula I compounds inhibit TOPK kinase activity by binding to its ATP-binding pocket.

Antioxidant mixtures protect pemetrexed disodium from oxidative degradation, maintaining chemical stability in aqueous parenteral solutions.

Combines TYK2 and MEK inhibitors to treat malignant peripheral nerve sheath tumors with inadequate current therapies.

Identifying AAV genotypes and molecular forms in liver tissue clarifies infection biology to improve gene therapy vector design.

Homogeneous morphine naloxone matrix prevents mechanical separation of active ingredients for oral substitution therapy.

Carboxylated starch derivatives maintain osmotic pressure during extended residence times, preventing negative ultrafiltration caused by solution dilution.

A controlled-release oral dosage form of ticagrelor utilizes a semi-permeable membrane and osmotic push layer to deliver medication over 24 hours.

Immunomagnetic sorting isolates functional stem cells to restore tissue regeneration capacity.

Palbociclib inhibits CDK4/6 activity to reduce right ventricle hypertrophy and improve pulmonary artery morphology in pulmonary arterial hypertension.

A novel synthesis route for lurasidone hydrochloride replaces hazardous reagents with safer borohydride alternatives.

Crenolanib overcomes resistance mutations in TRK fusion-positive cancers by maintaining therapeutic effectiveness against diverse kinase alterations.

N-piperidin-4-yl derivatives act as FSH receptor antagonists to suppress endometriosis progression without the flare effects of GnRH agonists.

A topical tranexamic acid composition stabilized with hydroxyethyl cellulose and buffered to maintain therapeutic efficacy at the wound site.

Segmented granulation maintains individual pharmacokinetic profiles of active ingredients to prevent drug-drug interactions and adverse events.

Titanium dioxide and dyes block light in the 200-550 nm range, limiting photodegradation products to less than 0.2% w/w.

Targeted polynucleotide compositions address the imbalance in bone resorption by regulating specific osteoclast differentiation markers.